The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

Overall, the 25 largest life science employers in Southern California have more than 28,000 employees combined.

Looking for the best biotech penny stocks ... the first publicly-owned biotech company, in 1976. Like many biotech startups today, Genentech started as a research initiative without any marketable ...

Many of the best biotech companies have both strong drug candidate pipelines and winning drugs already on the market. Image source: Getty Images. In January 2025, Axsome added a third product to ...

Unlike many unprofitable biotech companies ... immunology and cardiovascular therapeutics. The company’s top-selling drugs of 2022 include cancer therapies Revlimid and Opdivo and anticoagulant ...

To help you achieve the latter for your portfolio, Forbes Advisor has identified nine of the best biotech stocks. These companies have growing revenue and strong forward growth expectations.

These projects are expected to create new markets. We selected biotech companies with the best year-to-date (YTD) performance and a market cap of at least $10 billion. This ensured our focus on ...